4.5 Review

Research progress on circularRNAs in pancreatic cancer: emerging but promising

期刊

CANCER BIOLOGY & THERAPY
卷 20, 期 9, 页码 1163-1171

出版社

TAYLOR & FRANCIS INC
DOI: 10.1080/15384047.2019.1617563

关键词

Circular RNA; pancreatic cancer; biogenesis; biomarker; targeted therapy; immunotherapy

类别

资金

  1. China Academy of Medical Sciences Innovation Fund for Medical Sciences [2016-I2M-3-019]
  2. Non-profit Central Research Institute Fund of Chinese of Academy of Medical Sciences [2018PT32014]

向作者/读者索取更多资源

There is currently no diagnostic modality for early-stage pancreatic cancer. Given that adjuvant therapies require further development, the overall survival of pancreatic cancer remains unsatisfactory. Circular RNAs (circRNAs) are a class of noncoding RNAs that play an important role in the progression of many diseases including cancer. CircRNAs mainly bind to microRNAs as microRNA sponges to restore the expression of targeted genes and regulate tumor invasion, metastasis, proliferation, and apoptosis. CircRNAs also play roles in the diagnosis and targeted therapy of tumors. Studies on the mechanisms of action of circRNAs in pancreatic cancer are still in their infancy, but it is anticipated that this field will gradually advance. In this review, we provide a brief introduction to circRNAs from four perspectives: biogenesis, functions, and mechanisms of action, tumor therapy with circRNAs, and circRNAs' roles in pancreatic cancer.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据